Mathes Company’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Mathes Company’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$733K	Sell	46,000 -22,250	-33%	-$342K	0.23%	64
2026 Q1	$964K	Sell	68,250 -18,250	-21%	-$269K	0.35%	56
2025 Q4	$1.23M	Sell	86,500 -19,000	-18%	-$275K	0.44%	45
2025 Q3	$1.56M	Hold	105,500	–	–	0.56%	44
2025 Q2	$1.6M	Hold	105,500	–	–	0.59%	47
2025 Q1	$1.52M	Sell	105,500 -4,300	-4%	-$65.7K	0.62%	45
2024 Q4	$1.66M	Buy	109,800 +13,300	+14%	+$214K	0.61%	44
2024 Q3	$1.59M	Buy	96,500 +5,500	+6%	+$90.1K	0.56%	50
2024 Q2	$1.49M	Sell	91,000 -2,500	-3%	-$40.2K	0.54%	50
2024 Q1	$1.56M	Sell	93,500 -2,250	-2%	-$34.9K	0.58%	48
2023 Q4	$1.43M	Sell	95,750 -6,000	-6%	-$87.2K	0.59%	49
2023 Q3	$1.47M	Buy	101,750 +500	+0.5%	+$7.48K	0.68%	43
2023 Q2	$1.54M	Buy	+101,250	New	+$1.52M	0.68%	43
2022 Q4	$1.23M	Buy	88,500 +6,000	+7%	+$84.7K	0.62%	50
2022 Q3	$1.12M	Sell	82,500 -2,000	-2%	-$29.7K	0.63%	49
2022 Q2	$1.24M	Sell	84,500 -10,000	-11%	-$154K	0.6%	53
2022 Q1	$1.56M	Buy	94,500 +25,250	+36%	+$444K	0.61%	53
2021 Q4	$1.35M	Sell	69,250 -6,500	-9%	-$126K	0.46%	63
2021 Q3	$1.53M	Buy	75,750 +29,000	+62%	+$626K	0.57%	56
2021 Q2	$1.02M	Buy	46,750 +9,000	+24%	+$191K	0.37%	68
2021 Q1	$775K	Buy	37,750 +15,250	+68%	+$330K	0.3%	77
2020 Q4	$490K	Buy	22,500 +3,500	+18%	+$74.1K	0.2%	91
2020 Q3	$389K	Buy	+19,000	New	+$384K	0.18%	88

Other funds holding BCAT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mathes Company's BCAT Position: Q2 2026 in Review

Mathes Company reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 33% in Q2 2026, selling an estimated $342K and leaving 46,000 shares worth $733K. The position accounts for 0.23% of the portfolio, ranked #64.

Mathes Company first reported a position in BCAT in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.66M in Q4 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

Mathes Company held 46,000 shares of BlackRock Capital Allocation Term Trust worth $733K as of Q2 2026.
Mathes Company sold 22,250 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $342K.
BlackRock Capital Allocation Term Trust made up 0.23% of Mathes Company's portfolio in Q2 2026, its #64 holding.
Mathes Company first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 23 quarters since.
Mathes Company's BlackRock Capital Allocation Term Trust position peaked at $1.66M in Q4 2024.
110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.